ReShape Lifesciences Inc. (NASDAQ:RSLS) marked $0.50 per share on Monday, up from a previous closing price of $0.49. While ReShape Lifesciences Inc. has overperformed by 3.14%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RSLS fell by -87.35%, with highs and lows ranging from $4.18 to $0.46, whereas the simple moving average fell by -62.80% in the last 200 days.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Analysis of ReShape Lifesciences Inc. (RSLS)
Further, the quarter-over-quarter decrease in sales is -25.00%, showing a negative trend in the upcoming months.
In order to gain a clear picture of ReShape Lifesciences Inc.’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -117.60% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.40, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 202.44K can be a very valuable indicator of volatility for RSLS stock. On a monthly basis, the volatility of the stock is set at 8.00%, whereas on a weekly basis, it is put at 11.82%, with a loss of -10.34% over the past seven days. Furthermore, long-term investors anticipate a median target price of $3.83, showing growth from the present price of $0.50, which can serve as yet another indication of whether RSLS is worth investing in or should be passed over.
How Do You Analyze ReShape Lifesciences Inc. Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 6.10%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 18.40% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in RSLS shares?
The recent increase in stakes in RSLS appears to be a result of several institutional investors and hedge funds increasing their positions. The Vanguard Group, Inc.’s position in RSLS has decreased by 0.00% in the first quarter. The company now owns 499,359 shares of the stock, with a value of $0.29 million, following the sale of 0 additional shares during the last quarter. Geode Capital Management LLC made another increased to its shares in RSLS during the first quarter, upping its stake by 24.34%. During the last quarter, the company dropped down 54,933 additional shares for a total stake of worth $0.16 million, bringing number of shares owned by the company to 280,629.
During the first quarter, T. Rowe Price Associates, Inc. subtracted a 0 position in RSLS. Susquehanna Investment Group LLC sold an additional 4600.0 shares in the last quarter, decreasing its holdings by -3.67%, now holding 0.12 million shares worth $69644.0. At the end of the first quarter, HighPoint Advisor Group LLC decreased its RSLS holdings by 0.00% and now holds 37067.0 RSLS shares valued at $21388.0 with the lessened 0.0 shares during the period. RSLS shares are owned by institutional investors to the tune of 18.40% at present.